Synthesis, Characterization, in silico and in vitro Studies of Transition Metal Complexes with Biologically Active Ligand as Antigout Agent Colchicine
Abstract
Colchicine is essentially useful in the treatment of gout. In the present work Colchicine Complexes has been prepared with transition metals viz; Copper(II) [Cu(II)], Zinc (II) [Zn(II)], Cobalt (II) [Co(II)], Nickel (II) [Ni(II)] and those checked for molecular docking, it has been observed that Zn(II) and Ni(II) complex has revealed good binding energy than the parent ligand, the increased binding energy of colchicine metal complexes indicates that, the tubulin polymerization inhibitor tendency is enhanced, consequently antigout property is also increased. As transition metals have antimicrobial activity in themselves, complexes are also characterized for the antimicrobial activity which is enhanced for Cu(II) and Co(II) metals.
Keywords:
Colchicine complexes, molecular docking, gout, Beta tubulin inhibitor antimicrobial activity, IRDOI
https://doi.org/10.25004/IJPSDR.2020.120203References
Waziri I, Ndahi NP, Mala GA, Fugu MB. Synthesis, spectroscopic and biological studies of Cobalt (II), Nickel (II) and Iron (III) mixed antibiotic metal complexes. Scholars Research Library Der Pharma Chemica. 2014;6(5):118-122.
Sarwade SS, Jadhav WN, Khade WN. Characterization of novel complex ciprofloxacin Ag (I). Scholar Research Library. 2015;36-41.
Khade BC, Sarwade SS, Korde NS, Pawar RP. Equilibrium studies on mixed ligand complex formation of antiparasitic drug sulphadoxine and some amino acids with chromium (III). Pharm. Archives of Applied Science Research. 2015;7(1):36-41.
Tayde D, Sarwade SS, Jadhav WN, Khade BC. A study on the complexes of transition metals with nitazoxanide. Scholars Research Library Archives of Applied Science Research. 2015;7(1):28-35.
Gałczyńska K, Ciepluch K, Madej Ł, Kurdziel K, Maciejewska B, Drulis-Kawa Z, et al. Selective cytotoxicity and antifungal properties of copper (II) and cobalt (II) complexes with imidazole-4-acetate anion or 1-allylimidazole. Scientific reports. 2019;9(1):1-3.
Lapian LG, Thobias GP, Maengkom AO. The influence of boteme (SetariaItalica) against a decrease in the levels of uric acid in sufferers gout arthritis in the village of Gamsungi sub district of Tobelo North Halmahera. International Journal of Health Medicine and Current Research. 2018;3(2):920-924.
Kurek J, Bartkowiak G, Jankowski W, Kwaśniewska-Sip P, Schroeder G, Hoffmann M, et al. Human body fluid ions in colchicine complexes ESI MS, MADLI MS, spectroscopic, DFT studies and fungicidal activit y of colchicine complexes with sodium, potassium, magnesium and calcium carbonates and sulphates. IOSR J Pharm. 2016;6:40-55.
Sahakyan HK, Arakelov GG, Nazaryan KB. In silico Search for Tubulin Polymerization inhibitors., Molecular Biology, Springer. 2018;52(4):699-704.
Dalbeth N, Lauterio TJ, Wolfe HR. Mechanism of action of colchicine in the treatment of gout. Clinical therapeutics. 2014, 36(10):1465-1479.
Kurek J. Cytotoxic Colchicine Alkaloids: From Plants to Drugs. Cytotoxicity. 2018;6:45.
Ghawanmeh AA, Chong KF, Sarkar SM, Bakar MA, Othaman R, Khalid RM. Colchicine prodrugs and codrugs: Chemistry and bioactivities. European journal of medicinal chemistry. 2018;144:229-242.
Davis M, Wason S, DiGiacinto J. Colchicine-antimicrobial drug interactions: what pharmacists need to know in treating gout. The Consultant Pharmacist. 2013;28(3):176-183.
Padeh S, Gerstein M, Berkun Y. Colchicine is a safe drug in children with familial Mediterranean fever. The Journal of pediatrics. 2012;161(6):1142-1146.
Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine, 2017. Rheumatology. 2018;57:i4-11.
Sabale V, Ingale A. Homology Modeling and Structural Validation Studies of 3 Oxoacyl (Acyl Carrier Protein) Synthase II and Dihydropteroate Synthase Protein of Neisseria meningitides. J. Appl. Bioinforma. Computational Biololy. 2017;6(2):01-10.
Kurek J, Barczyński P. Colchiceine Complexes with Lithium, Sodium and Potassium Salts− Spectroscopic Studies. CroaticaChemica Acta. 2016;89(3):297-308.
Rasheed K, Sultana N, Tariq MI, Ahmad SA, Munir C. Synthesis, characterization and biological studies of metal complexes of an oral hypoglycemic sulfonylurea drug, glibenclamide. Science International. 2015;27(3).
Khade BC, Deore PM. Studies on Metal Complexes of Some Non-Essential Amino Acids with Copper (II). International Journal of Universal Science and Technology. 2018;3(1):47-51.
Khade BC. Potentiometric studies on chromium (iii) metal complexes with high ceiling diuretic drug furosemide and biological important ligand in 80% ethanol–water mixture. World Journal of Pharmacy and Pharmaceutical Sciences. 4(4);1694-1702.
Khade BC, Deore PM, Arbad BR. Mixed-ligand complex formation of copper (II) with some amino acids and Drug Dapsone. Int. J. Chemtech Res. 2010;2:1036-1041.
Majcher U, Klejborowska G, Moshari M, Maj E, Wietrzyk J, Bartl F, Tuszynski JA, Huczyński A. Antiproliferative Activity and Molecular Docking of Novel Double-Modified Colchicine Derivatives. Cells. 2018;7(11):192.
Wang Y, Zhang H, Gigant B, Yu Y, Wu Y, Chen X, Lai Q, Yang Z, Chen Q, Yang J. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery. The FEBS journal. 2016;283(1):102-111.
Jankowski W, Kurek J, Barczyński P, Hoffmann M. Quantumchemical, NMR, FT IR, and ESI MS studies of complexes of colchicine with Zn (II). Journal of molecular modelling. 2017;23(4):127.
Jamkhande PG, Ghante MH, Ajgunde BR. Software based approaches for drug designing and development: A systematic review on commonly used software and its applications. Bulletin of Faculty of Pharmacy, Cairo University. 2017;55(2):203-210.
Maithri G, Manasa B, Vani SS, Narendra A, Harshita T. Computational drug design and molecular dynamic studies-a review. Int J Biomed Data Min. 2016;6(1):1-7.
Sabale V, Ingale A. Homology modeling and docking studies of 3-oxoacyl synthase II protein of Neisseria meningitides. International Journal of Scientific & Engineering Research. 2016;7(8):1564-1572.
Pascart T, Richette P. Current and future therapies for gout. Expert opinion on pharmacotherapy, Taylor &Francis 2017;18(12):1201-1211.
Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Archives of internal medicine. 2009;69(5):502-507.
Alberts BM, Barber JS, Sacre SM, Davies KA, Ghezzi P, Mullen LM. Precipitation of Soluble Uric Acid Is Necessary for in vitro activation of the NLRP3 inflammasome in primary human monocytes. The Journal of rheumatology. 2019;46(9):1141-50.
Cavagna L, Taylor WJ. The emerging role of biotechnological drugs in the treatment of gout. BioMed research international. 2014;1-9.
Published
Abstract Display: 687 
PDF Downloads: 455 
